3.4. Safety Parameters
Hematological, blood-biochemical, and urine analyses were performed at baseline and after 12 weeks of treatment. The results of blood counts, biochemical tests, and diagnostic tests (hematology, blood chemistry, and urine) in the BRE group showed no statistically significant difference before and after intake. Furthermore, systolic and diastolic blood pressure, pulse rate, body temperature, and other vital signs remained within the normal range. All the laboratory profiles of the subjects are shown in 